Search Results 3841-3850 of 28477 for oral
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Following the lead-in, a phase 2, randomized, double blind, 2 arm study of oral single agent PF 04449913 versus placebo will be tested in patients resistant ...
... oral anticoagulants is not an exclusion if estimated GFR > 30 ml/min). Seizures at stroke onset if it precludes obtaining an accurate baseline NIHSS ...
Subjects currently receiving oral anticoagulants (ie, warfarin/other vitamin K antagonists or direct-acting oral anticoagulants \[DOACs\]) if any of the ...
Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is ...
... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...
Receiving systemic immunosuppressive therapy (> 2 weeks) including oral steroid doses > 10 mg/day of prednisone or equivalent within 2 months prior to ...
In: Oral and Maxillofacial Surgery. 3rd ed. St. Louis, Mo.: Elsevier; 2018. https://www.clinicalkey.com. Accessed July 29, 2018. Chaffoo RA. Complications ...
Research · Improving and adapting existing robotic surgery systems for use on tumors of the tongue. · Investigating tumor growth factors for oral cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.